C.K. Cooper Downgrades Nabi Biopharmaceuticals (NABI) to Hold
Tweet
Share
E-mailGet Alerts NABI Hot Sheet
Price: $1.80 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
C.K. Cooper downgraded Nabi Biopharmaceuticals (NASDAQ: NABI) from Buy to Hold.
For more ratings news on Nabi Biopharmaceuticals click here and for the rating history of Nabi Biopharmaceuticals click here.
Shares of Nabi Biopharmaceuticals closed at $5.63 yesterday.
For more ratings news on Nabi Biopharmaceuticals click here and for the rating history of Nabi Biopharmaceuticals click here.
Shares of Nabi Biopharmaceuticals closed at $5.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
- Nomura/Instinet Downgrades Petpal Pet Nutrition Technology (300673:CH) to Neutral
- Kepler Cheuvreux Downgrades DiaSorin SpA (DIA:IM) (DSRLF) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
CK CooperSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
